검색
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR관심 목록에 추가
0.081USD
+0.000+0.25%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 회사
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 정보
종목 코드 DMIIR
회사 이름Drugs Made In America Acquisition II Corp
상장일Sep 25, 2025
CEOStockwell (Lynn)
직원 수- -
유형Right
회계 연도 종료- -
주소1 East Broward Boulevard
도시FT LAUDERDALE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33301
전화19548703099
웹사이트
종목 코드 DMIIR
상장일Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
자주 묻는 질문
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030의 상위 5대 주주는 누구인가요?
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030의 상위 5대 주주는 다음과 같습니다: Ms. Lynn Stockwell